Safety & Risks
How reliable are CBD products?
TL;DR — What the Evidence Shows
Studies find most CBD products are mislabeled. Some contain undisclosed THC, heavy metals, or pesticides. No government agency tests CBD products before they are sold.
How often are CBD products mislabeled?
Multiple independent studies have tested CBD products purchased from retailers. They consistently find that most products do not contain the amount of CBD stated on the label.
| Study | Products tested | Accurately labeled |
|---|---|---|
| Bonn-Miller et al., JAMA, 2017 | 84 | About 3 out of 10 |
| Spindle et al., JAMA Netw Open, 2022 | 89 | About 2 out of 10 |
| Gidal et al., Front Pharmacol, 2024 | 202 | About 3 out of 10 |
| Kinghorn et al., Sci Total Environ, 2022 | 516 | About 4 out of 10 |
| FDA Marketplace Surveillance, 2020 | 147 | About 1 out of 3 (within 20%) |
"Accurately labeled" means the actual CBD content fell within 10% of the label claim (the US Pharmacopeia threshold). The FDA study used a more lenient 20% threshold. Human Trial
About 1 in 4 products do not even match the type claimed on the label. A product labeled "full spectrum" may lack expected cannabinoids. A product labeled "THC free" may contain detectable THC.
Source: (Gidal 2024): 26% of 202 products tested did not meet their claimed product type definition.
What contaminants have been found?
Hemp plants are bioaccumulators. They absorb substances from the soil, including heavy metals, pesticides, and other environmental contaminants. Combined with the absence of premarket testing, this creates a documented contamination problem.
| Contaminant | How common | Key finding |
|---|---|---|
| Lead | About 4 out of 10 edible products | Four products exceeded California's daily lead safety threshold. Lead accumulates over a lifetime. |
| Mercury | About 37 out of 100 edible products | Mercury damages the nervous system and kidneys. |
| Pesticides | About 15 out of 100 products | 26 different pesticides detected across 30 of 202 products. 17 products exceeded regulatory limits. |
| Residual solvents | About 9 out of 10 products | Hexane, xylene, and methanol were most common. 19 products exceeded regulatory thresholds. |
| Undisclosed THC | About 2 to 5 out of 10 products | Found even in products labeled "THC free." Can cause confusion in seniors and trigger positive drug tests. |
Sources: (Kinghorn 2022) (Gidal 2024) (Bonn-Miller 2017) (Spindle 2022)
Why isn't this regulated?
The FDA has not approved any CBD product for arthritis or pain. The only FDA-approved CBD product is Epidiolex, a prescription medication for rare seizure disorders.
The FDA's position is that CBD cannot legally be marketed as a dietary supplement. This means there is no premarket testing requirement. No government agency tests CBD products for safety, purity, or accuracy before they reach store shelves.
FDA enforcement has focused on companies making disease treatment claims, products appealing to children, and products with novel delivery methods. It has not focused on labeling accuracy or contamination in the broader market.
Source: (FDA Marketplace 2020) Statement, January 26, 2023. "Existing Regulatory Frameworks...Not Appropriate for Cannabidiol."
What is a Certificate of Analysis?
A Certificate of Analysis (COA) is a document from a testing laboratory that details the chemical analysis of a specific product batch. It is the closest thing to independent quality verification available to a consumer.
A credible COA should include the laboratory name and accreditation, a batch number matching your product, a cannabinoid profile, and panels for heavy metals, pesticides, residual solvents, and microbial contamination. If any panel is missing, the testing is incomplete.
Only about 7 out of 100 CBD brands conduct legitimate contamination testing for pesticides, heavy metals, and microbial contamination.
For a step-by-step guide to reading and verifying a COA, see How to Evaluate a CBD Product.
How to Evaluate a CBD Product →
COA reading guide, red flags checklist, and third-party certification programs.
Drug Interactions →
CBD affects liver enzymes that process about 60 out of 100 prescription drugs.
Key sources cited on this page
Page last reviewed: March 2026 · Authored by Claude (Anthropic AI) · Research methodology